(HealthDay)—A new drug significantly reduces the abdominal pain and constipation characteristic of certain types of irritable bowel syndrome, according to two new studies.
Sep 18, 2012
0
0
Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown.
Nov 2, 2011
0
0
Taking higher-than-recommended doses of vitamin D for five years reduced the risk of atrial fibrillation in older men and women, according to a new study from the University of Eastern Finland.
Jun 27, 2023
0
24
Long-term exposure to air pollution is tied to an increased risk of having a heart attack or dying from heart disease—with the greatest harms impacting under-resourced communities, new Kaiser Permanente research shows.
Feb 24, 2023
0
74
Folic acid fortification of foods may reduce the incidence of the most common type of kidney cancer and a type of brain tumors in children, finds a new study by Kimberly J. Johnson, PhD, assistant professor at the Brown School ...
May 21, 2012
0
0
(Medical Xpress) -- A new University at Albany study finds background exposure to levels of mercury and cadmium commonly found in the environment may significantly interfere with early pregnancy through in-vitro fertilization ...
Jul 19, 2012
0
0
Despite dramatic progress in reducing Americans' exposure to lead over the past 25 years, a growing body of research finds that children and adults still face health risks from even very low levels of the toxic metal in their ...
Jul 17, 2012
0
0
Girls between 9 and 12 years of age with higher-than-average levels of bisphenol-A (BPA) in their urine had double the risk of being obese than girls with lower levels of BPA, according to a Kaiser Permanente study published ...
Jun 12, 2013
0
0
Lead is a common element but is found in old paints (including those once used on children's toys), soil, old piping, water, and the atmosphere from lead-containing vehicular fuels, even drinking vessels. At high dose it ...
Feb 11, 2013
0
0
A study by Hans-Peter Hartung, M.D., of Heinrich-Heine-Universität, Düsseldoft, Germany, and colleagues examines the association between IL-17F and treatment response to interferon beta-1b among patients with relapsing-remitting ...
Jun 3, 2013
0
0
